ALCOX:EPA
NicOx SA
€ 0.32
arrow_downward
-1.08%(-0.0035) 1D
10-р сарын 2, 17:35:29 (GMT+2) · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCOX...
Open
€ 0.32
High
€ 0.33
Low
€ 0.32
Mkt. cap
30.89 сая
Avg. vol.
160.60 мян
Volume
280.19 мян
52-wk high
€ 0.57
52-wk low
€ 0.28
EPS
-€ 0.03
Shares outstanding
97.55 сая
No. of employees
10
Open
€ 0.32
High
€ 0.33
Low
€ 0.32
Mkt. cap
30.89 сая
Avg. vol.
160.60 мян
Volume
280.19 мян
52-wk high
€ 0.57
52-wk low
€ 0.28
EPS
-€ 0.03
Shares outstanding
97.55 сая
No. of employees
10
News stories
From web sources and news partners
The National Law Review
·
11 минутын өмнө
Kaplan Fox Encourages Honeywell Aerospace Inc. (NASDAQ: HONA) Inv
TradingView
·
1 цагийн өмнө
Greenland Mines (NASDAQ: GRML) Management Outlines Pipeline, Path from Exploration to Production
MarketBeat
·
2 минутын өмнө
MakeMyTrip (NASDAQ:MMYT) Stock Price Down 5.6% - Time to Sell?
Yahoo Finance
·
2 цагийн өмнө
1 S&P 500 Stock to Research Further and 2 Facing Headwinds
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees10
Founded1996
HeadquartersValbonne, Provence-Alpes-Côte d'Azur, Франц
Sector-
Websitenicox.com